155 related articles for article (PubMed ID: 32406319)
1. Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer.
Ma J; Qi J; Li S; Zhang C; Wang H; Shao L; Yuan X; Sha Q
Technol Cancer Res Treat; 2020; 19():1533033820926591. PubMed ID: 32406319
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.
Park SL; Cho TM; Won SY; Song JH; Noh DH; Kim WJ; Moon SK
Oncol Rep; 2015 Sep; 34(3):1605-12. PubMed ID: 26166554
[TBL] [Abstract][Full Text] [Related]
3. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
4. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
5. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
6. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
8. Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis.
Lyu L; Huang LQ; Huang T; Xiang W; Yuan JD; Zhang CH
Drug Des Devel Ther; 2018; 12():743-756. PubMed ID: 29670331
[TBL] [Abstract][Full Text] [Related]
9. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of growth, migration and invasion of human bladder cancer cells by antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, and its molecular mechanisms.
Chiu KY; Wu CC; Chia CH; Hsu SL; Tzeng YM
Cancer Lett; 2016 Apr; 373(2):174-84. PubMed ID: 26679052
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the SDF‑1/CXCR4/β‑catenin axis contributes to bladder cancer cell growth inhibition in vitro and in vivo.
Zhang T; Yang F; Li W; Liu B; Li W; Chen Z; Wang C
Oncol Rep; 2018 Sep; 40(3):1666-1674. PubMed ID: 30015971
[TBL] [Abstract][Full Text] [Related]
13. Impact of desloratadine and loratadine on the crosstalk between human keratinocytes and leukocytes: Implications for anti-inflammatory activity of antihistamines.
Traidl-Hoffmann C; Münster I; Ring J; Behrendt H
Int Arch Allergy Immunol; 2006; 140(4):315-20. PubMed ID: 16741367
[TBL] [Abstract][Full Text] [Related]
14. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
[TBL] [Abstract][Full Text] [Related]
16. Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule 1 upregulation and promoter activation in respiratory epithelial cells.
Papi A; Papadopoulos NG; Stanciu LA; Degitz K; Holgate ST; Johnston SL
J Allergy Clin Immunol; 2001 Aug; 108(2):221-8. PubMed ID: 11496238
[TBL] [Abstract][Full Text] [Related]
17. Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor-Mediated MMP-9 Expression.
Shin SS; Won SY; Noh DH; Hwang B; Kim WJ; Moon SK
Drug Dev Res; 2017 Mar; 78(2):81-90. PubMed ID: 28176369
[TBL] [Abstract][Full Text] [Related]
18. Antitumor Effects of Ruyiping on Cell Growth and Metastasis in Breast Cancer.
Li Z; Sun X; Liu X; Sun Z; Li J
Cancer Biother Radiopharm; 2019 Jun; 34(5):297-305. PubMed ID: 30901274
[No Abstract] [Full Text] [Related]
19. Triacanthine exerts antitumor effects on bladder cancer in vitro and in vivo.
Shin SS; Park YJ; Hwang B; Park SL; Han SW; Park SS; Choi YH; Kim WJ; Moon SK
Phytomedicine; 2019 Nov; 64():153069. PubMed ID: 31421400
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine.
Schroeder JT; Schleimer RP; Lichtenstein LM; Kreutner W
Clin Exp Allergy; 2001 Sep; 31(9):1369-77. PubMed ID: 11591186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]